LMNOX Mutual Fund
LMNOX Mutual Fund
LMNOX Mutual Fund
Patient Opportunity Trust Class I
LMNOX Mutual Fund Overview
LMNOX Mutual Fund (Patient Opportunity Trust Class I) is managed by Patient Capital Management with $1.05B in net assets. LMNOX expense ratio is 1.39%, holding 38 positions across sectors including Financials, Information Technology, Health Care. Inception date: 2000-06-26.
LMNOX performance shows a YTD return of 10.78%. The 1-year return is 16.19% and the 5-year return is 8.00%. LMNOX dividend yield stands at 0.14%, paid annually.
LMNOX top holdings include Royalty Pharma Plc Class A Ordinary Share (6.1%), Citigroup Inc. (5.7%), Alphabet Inc (5.7%), Precigen Warrant Restricted 12/30/2034 (5.6%), Amazon.Com Inc (5.2%). Go to all LMNOX holdings, LMNOX sectors, or LMNOX dividends.
LMNOX can be compared against other funds. Use LMNOX overlap to find shared positions, or LMNOX vs another fund for a side-by-side view. LMNOX alternatives are available via the screener, along with tax-loss harvesting opportunities.